Transverse Myelitis Trial, Recruiting (NCT05154370)

Transverse Myelitis Trial, Recruiting NCT05154370 Sponsor: Beijing Tiantan Hospital Condition: Transverse Myelitis

Printed from Voxsanity (voxsanity.com.au) — NCT05154370 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Transverse Myelitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any age and any sex are welcome to apply.
You must have been diagnosed with at least one of the following conditions: clinically isolated syndrome (CIS), multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), MOG antibody-associated disease (MOGAD), or acute disseminated encephalomyelitis (ADEM).
You (or your legal representative) must be willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

People who have a severe mental health condition that would make it difficult for them to participate in examinations or attend follow-up appointments may not be eligible.
Anyone who is unable to sign the consent form, or who does not wish to sign it, cannot join — this also applies if a legal representative is required to sign on the patient's behalf and they are unable or unwilling to do so.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8610-59976585

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05154370

Sponsor: Beijing Tiantan Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Transverse Myelitis

Trial contact: 8610-59976585

More information: https://clinicaltrials.gov/study/NCT05154370

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any age and any sex are welcome to apply.
You must have been diagnosed with at least one of the following conditions: clinically isolated syndrome (CIS), multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), MOG antibody-associated disease (MOGAD), or acute disseminated encephalomyelitis (ADEM).
You (or your legal representative) must be willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

People who have a severe mental health condition that would make it difficult for them to participate in examinations or attend follow-up appointments may not be eligible.
Anyone who is unable to sign the consent form, or who does not wish to sign it, cannot join — this also applies if a legal representative is required to sign on the patient's behalf and they are unable or unwilling to do so.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Beijing Tiantan Hospital

Registry

ClinicalTrials.gov

Start date

15 December 2021

Est. completion

1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Annual relapse rate (ARR) between baseline and follow-up in patients with IDD; Change in EDSS scores of patients with IDD between baseline and follow-up over time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov